๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Biocon Limited (BOM:532523)
India flag India ยท Delayed Price ยท Currency is INR
366.00
+3.65 (1.01%)
At close: Nov 20, 2026

Biocon Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
174,145169,270152,617147,557111,74281,840
Revenue Growth
5.70%10.91%3.43%32.05%36.54%14.57%
Gross Profit
107,170102,66492,44191,73569,61750,111
Operating Income
15,87716,94315,43117,83415,64311,583
Net Income
4,5213,85610,13310,2254,6276,484
Earnings Per Share
2.942.828.468.543.875.42
EPS Growth
-24.70%-66.67%-0.94%120.67%-28.60%-12.44%

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Biosimilars
109,165104,31290,17488,24255,83834,643
Generics
33,70731,68130,17527,98527,64423,409
Services
35,22337,38736,42434,88631,92926,042
Inter-Segment
-3,950-4,110-4,156-3,556--
Total
174,145169,270152,617147,557111,74281,840

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
26,86738,83145,65125,74037,26329,649
Total Debt
156,978154,341183,620162,767180,18851,468
Net Cash (Debt)
-130,111-115,510-137,969-137,027-142,925-21,819
Net Cash Growth
------
Net Cash Per Share
-84.54-84.40-115.15-114.49-119.51-18.24

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
19,59619,94040,61229,53918,52511,766
Capital Expenditures
-16,249-17,979-21,366-16,805-15,960-16,978
Free Cash Flow
3,3471,96119,24612,7342,565-5,212
Free Cash Flow Growth
-82.88%-89.81%51.14%396.45%--

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
61.54%60.65%60.57%62.17%62.30%61.23%
Operating Margin
9.12%10.01%10.11%12.09%14.00%14.15%
Pretax Margin
2.08%2.65%12.36%10.34%8.03%12.01%
Profit Margin
2.60%2.28%6.64%6.93%4.14%7.92%
FCF Margin
1.92%1.16%12.61%8.63%2.30%-6.37%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
0.5000.5000.5000.5001.5000.500
Dividend Per Share Growth
0%0%0%-66.67%200.00%-
Dividend Yield
0.14%0.14%0.15%0.19%0.73%0.15%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
124.50151.4740.3630.8553.2161.56
P/FCF Ratio
177.28297.8421.2524.7795.98-
PS Ratio
3.413.452.682.142.204.88